Novatel Wireless, Inc. (NVTL) Receives 2012 Mobile Merit Awards in ‘Gadgets, Handsets, and Devices’ and ‘Mobile Health’ Categories

Leading intelligent wireless solutions provider Novatel Wireless announced today its 4G LTE MiFi 4620L Intelligent Mobile Hotspot has been selected as a winner in the gadgets, handsets, and devices category for the 2012 Mobile Merit Awards for the third year in a row; the company was also selected as a winner in the mobile health category.

Novatel Wireless is a leader in the mobile broadband industry, bringing mobile broadband devices to the next generation. The company’s MiFi platform is the industry’s first intelligent mobile hotspot, and the mobile broadband device allows users to hold their worlds of content, services, and connectivity in the palms of their hands. The device creates a personal Wi-Fi cloud that is capable of sharing high-speed 4G LTE mobile broadband Internet connectivity with up to 10 Wi-Fi-enabled devices all at once, including laptops, tablets, gaming devices, and multimedia players. The MiFi 4620L is also a global ready device, offering the ultimate online experience for users desiring to stay connected while traveling internationally and giving consumers and business travelers Web access in more than 205 countries. Another of the device’s features is an extended battery pack accessory, and it also comes equipped with an interactive OLED display. The MiFi 4620L is currently available through Verizon Wireless.

Selected a winner in the mobile health category, in collaboration with VGo Communications, the Novatel Wireless Expedite E362 PCI Express Mini Card for 4G LTE, integrated in the VGo robot, allows users to be anywhere at any time by providing remote-controlled robotic tele-presence. VGo has effectively created a solution for two of the major challenges in healthcare today – skilled resources availability and cost containment – by creating an easy-to-use platform that allows users to “be there without being there.” This technology reduces costs and increases productivity by allowing staff to instantly travel across distances at the push of a button – whether to a patient’s bedside, a lab, a clinic, an elderly facility, or a home.

Headquartered in San Diego, Calif., Novatel Wireless is an industry leader in designing and developing intelligent wireless solutions based on 2G, 3G, and 4G technologies. The company provides specialized wireless solutions for carriers, distributors, retailers, OEMs, and vertical markets worldwide, and its Intelligent Mobile Hotspot products, software, USB modems, embedded modules, and smart M2M modules provide customers with anytime, anywhere communications solutions.

For more information, visit www.novatelwireless.com

About MissionIR 

MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.

Sign up for “The Mission Report” at www.MissionIR.com

Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html

Kodiak Oil & Gas Corp. (KOG) Updates Investors on Q1 2012 Activity

Kodiak Oil and Gas released a financial and operational update for the first quarter of 2012. The company is actively developing the Bakken play in the Williston Basin of North Dakota.

Kodiak Oil reported oil and gas production of 10,578 barrels of oil equivalent (BOE) per day in the quarter ending March 31, 2012. This represented 467% year-over-year production growth and 47% sequential growth. The management of Kodiak Oil attributed the strong production growth to an acquisition in 2011 and more efficient operations.

Kodiak Oil has increased the company’s operated rig count in the Williston Basin to six rigs and plans to take delivery of a seventh rig during the current quarter. The company also has a dedicated hydraulic fracturing fleet that works exclusively on its operations, and plans to add a second fleet shortly.

Kodiak Oil is growing so rapidly that the company is experiencing a backlog of wells in its inventory. The company currently has 14 gross wells that have been drilled and are awaiting hydraulic fracturing operations. Kodiak Oil estimates that the company will complete 12 of these wells during the second quarter of 2012.

For more information on the company, go to www.kodiakog.com

About MissionIR 

MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.

Sign up for “The Mission Report” at www.MissionIR.com

Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html

VistaGen Therapeutics (VSTA) Develops Superior Drug Testing Technology

Human pluripotent stem cells are the foundation for VistaGen’s development of advanced stem cell technologies to create superior drug testing opportunities for pharmaceutical companies. Pluripotent stem cells are able to self-renew as well as differentiate into specialized cells like heart and liver cells. They can be grown indefinitely in vitro. The company’s Human Clinical Trials in a Test Tube approach uses human heart and liver cells, derived from stem-cells, for highly accurate early laboratory testing of drug candidates, before the investment in further development or clinical trials. Such early-stage testing can save drug producers tremendous money and time.

New technologies allow pluripotent stem cells to be obtained without the use of embryos. Induced pluripotent stem cells are adult cells, usually skin cells, genetically engineered to function like embryonic derived stem cells. The result is a source of ideal research tools. Using proprietary and licensed technology, VistaGen uses these cells to create customized human heart and liver cell based bioassay systems to test new drug candidates for toxicity. Use of this approach has the potential to substantially reduce the staggering failure costs that often accompany new drug development.

The VistaGen testing platform allows assessment of the heart toxicity profile of new drug candidates for a wide range of diseases and conditions with greater speed and precision than non-clinical animal testing or traditional in-vitro cell culture based techniques. Compared to standard 2D cell based assays, VistaGen’s 3D cell networks and structures are considered to better reflect human body biology, yielding toxicity test results that are more relevant and predictive of human drug responses. The same is true of their work with liver cells.

It’s an approach that is timely, since the U.S. faces a growing crisis in the development and approval of new drugs. The number of new drugs approved by the FDA has dropped dramatically over the past decade, in spite of increased R&D funding by the pharmaceutical industry. Lost money due to drug candidates that ended up having to be withdrawn after lengthy investment is a contributing factor. The VistaGen solution directly addresses this critical issue.

For additional information, visit the company’s website at www.VistaGen.com

About MissionIR 

MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.

Sign up for “The Mission Report” at www.MissionIR.com

Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html

NDB Energy, Inc. (NDBE) is “One to Watch”

NDB Energy is an emerging independent oil and gas company that explores for, develops, produces, and markets crude oil and natural gas from various known prolific and productive geological formations. The company is focused on building and developing a portfolio of oil and gas assets by acquiring what it views as undervalued, underdeveloped, and underperforming properties, and for which it thinks it can profitably and economically increase production economically and profitably. Currently, the company’s primary operations are in Texas.

NDB Energy is capably led by James Cerna. Mr. Cerna’s experience includes serving as a successful company leader in the energy industry and publicly traded companies. Mr. Cerna has served as an executive and director with companies listed on the NYSE Amex, Nasdaq, and OTCBB markets. Mr. Cerna has received five certificates of achievement from the Institute of Chartered Financial Analysts. He is honored by Strathmore’s Who’s Who for leadership and achievement in the Finance Industry.

Recently, the company made a bolt-on acquisition of Armada Oil, Inc., an independent energy company engaged in the exploration of shale oil. Armada’s primary operations and assets extend the company’s range to the Laramie and Hanna Basins in Southern Wyoming. Most importantly, Armada holds interests in Carbon County, Wyoming, that includes a 25,000+ acre Niobrara and Casper formation project near existing infrastructure including oil and natural gas pipelines, oil refineries, and gas processing plants, as well as various productive oil and natural gas fields.

The Niobrara shale formation is considered an unconventional oil play. It is regarded by some as one of the coming major resource areas. In fact, it has been compared to the successful Bakken shale formation. Technological advances in horizontal drilling and hydraulic fracturing in the last decade have helped create this opportunity as it did with the Bakken field.

Commenting on the Armada acquisition, Mr. Cerna said, “This acquisition is an important corporate milestone for our Company. Our mission to develop and commercialize high-value domestic onshore properties fits well with Armada, which has control of over 25,000 net acres with seismic and previous well control indicating a potential Niobrara opportunity. Further, there are several additional pay zones within the property, which we plan to test, including a deeper conventional Tensleep formation. Engineering progress has been made and we intend to further this work with additional 3D seismic and drilling this year.”

For more information on the company, visit www.ndbenergyinc.com

About MissionIR 

MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.

Sign up for “The Mission Report” at www.MissionIR.com

Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html

Autobytel, Inc. (ABTL) Profitably Matches Consumers to Car Dealers Online

Autobytel helps consumers find cars and obtain financing, and provides other services over the Internet. Located in California, Autobytel has been in business since 1995 and pioneered online auto marketing. Autobytel is well positioned to benefit as, more and more, consumers are turning to the Internet to find cars and work with car dealers to get prices and make purchases.

For example, according to J.D. Powers and Associates, 81% of consumer purchases of new light vehicles were made using the internet as the primary source of information and decision-making. In fact, consumers now use the internet more than either television or magazines when making a vehicle purchase. The forecast for auto sales and Autobytel looks promising: car sales are estimated for 2012 to be between 13.7 and 14 million, compared to 12.7 million in 2011 and 11.6 million for 2010.

Here’s how it works. Using Autobytel, a consumer can get information and tools to them to aid them with their automotive purchase decisions. Consumers also have the ability to submit inquiries directly to car dealers to contact them regarding purchasing or leasing vehicles. Even for consumers who may not be able to secure loans through conventional lending sources, Autobytel provides the ability to submit inquiries requesting dealers or other lenders that may offer vehicle financing to them. On average, US consumers buy a car every 3 to 7 years. Autobytel’s goal is to be a consumer’s “Lifetime Automotive Advisor” for each of the consumer’s auto purchases. It is revamping its operations to focus more intently on the “Lifetime Automotive Advisor” theme.

So how does the company monetize consumer information requests? Autobytel does not charge a consumer any fees for using its site. Autobytel sells the consumer information requests and inquiries to car dealers, manufacturers, and lenders. By tracking how many consumers who request dealer information actually make a purchase, Autobytel provides timely and valuable intelligence to its customers.

Last year was a breakthrough year financially for the company. Gross profit grew 20% to $6.9 million for the 2011 fourth quarter from $5.8 million for the prior year’s fourth quarter. Gross margin improved to 42.5% of total revenues for the 2011 fourth quarter from 39.3% for the fourth quarter of 2010. The improvement in gross margin was in part the result of a greater level of website inquiries sold to its customers. Net income for the 2011 fourth quarter totaled $341,000, or $0.01 per diluted share. With the increased demand for autos, Autobytel’s prospects are looking up.

For more information on the company, visit www.autobytel.com


About MissionIR 

MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.

Sign up for “The Mission Report” at www.MissionIR.com

Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html

NDB Energy, Inc. (NDBE) Acquires Armada Oil, 25k Acres of Prime Niobrara Shale/Casper Sandstone Targets

NDB Energy, the aggressive, emerging oil and gas company, running the gamut operationally from exploration to production and marketing, via an ever-growing portfolio of carefully chosen undervalued, underdeveloped, and underperforming targets, recently reported yet another judicious growth initiative, securing key acreage (including a choice, 25k-acre project targeting the Niobrara/Casper formations) in Carbon County, Wyoming, through the successful acquisition of Armada Oil, Inc.

The Armada acquisition not only includes the obvious prime territory targets in Carbon County (that is ideally situated near abundant existing pipelines, refining/processing infrastructure, and other producing fields), but several additional pay zones as well that the company plans to test. The 25k acres over which Armada has control was developed as part of Armada’s overall Southern Wyoming strategy, which emphasized shale oil exploration projects in and around the Laramie and Hanna Basins.

The acquisition was completed via a share exchange agreement (to date Armada has 1,280 acres acquired, along with the important 2D seismic, and well control/engineering data on the project, as well as the option to buy an additional 23.7k plus acres) and places Armada under the umbrella of a public company for the first time, bringing the vast oil and gas exploration experience of Armada to NDBE’s bottom line. Armada is now a wholly-owned subsidiary of NDBE and is able to punch above its weight, while NDBE gains a strong foothold in the Niobrara shale.

President of Armada Oil, David Moss, noted the broad access to capital markets and improved workflow timeline this deal implements, explaining that the project could be advanced much more quickly now, driving shareholder value both through development, and through increasing the overall acreage position in Wyoming.

President and CEO of NDBE, James J. Cerna, called it a real milestone for the company, landing such a major growth deal in prime acreage, and commended Armada’s strategy to identify/exploit resources of potential shale/sandstone reservoirs in the upper and lower Permian-Pennsylvanian age Niobrara/Casper formations. Cerna explained that the acquisition was directly in line with NDBE’s focus on developing/commercializing “high-value domestic onshore properties.”

Cerna also noted the additional payzones, including deeper, conventional Tensleep Sandstone formation targets. Cerna underscored the progress made thus far from an engineering standpoint on the property and stressed the eagerness of NDBE to conduct more thorough analysis, including 3D seismic and drilling in 2012.

This acquisition adds quite nicely to NDBE’s already solid footprint in Texas via the company’s Young County property and the Eagle Ford shale play target property in Gonzales County. While the Niobrara shale is considered an unconventional play, the clear analogy to the Bakken is there, and it’s a potential up and comer on par with the Bakken due to advances in horizontal drilling, as well as hydraulic fracturing.

The big boys like Anadarko, Chesapeake, EOG, and Noble are just getting their feet wet in the Niobrara really. Getting in at these earlier stages with key acreage gives NDBE incredible hitting power, especially long-term. Superb steering of the company ship by NDBE’s management, as gas prices rise amid cooler spring weather and oil holds at around $103, despite implacable woes over EU sovereign debt dynamics. Many people say the economy is slowing down, but domestic onshore oil and gas just gets hotter every day, driven by a whole series of component market vectors.

For more information on the Armada acquisition, or to learn more about NDB Energy, Inc., please visit the company’s website at: www.NDBEnergyInc.com

About MissionIR 

MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.

Sign up for “The Mission Report” at www.MissionIR.com

Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html

SEFE, Inc. (SEFE) Provides Overview of Tether Contact System

Today, SEFE, a technology- and solutions-driven sustainability company, introduced a summary of its tether contact system and its role in the company’s flagship Harmony III product.

The tether contact system is designed to minimize electrical path length on the power tether. Using a proprietary mechanism, the system completes the power circuit, removing the unused power tether from the path. It functions in tandem with the dynamic electrical converter and the electrostatic motor-generator as an efficiency booster, allowing the same hardware to be used no matter what the flight elevation of the aerostat will be.

“The most oft-asked questions about the design of our system are related to its safety and efficiency. This component of our system is one of several inventions geared toward addressing both of those issues in order to enhance the product as a whole,” stated Mike Hurowitz, SEFE’s Director of Engineering.

For more information visit www.SEFElectric.com

About MissionIR 

MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.

Sign up for “The Mission Report” at www.MissionIR.com

Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html

Zalicus, Inc. (ZLCS) Finalizes Patient Enrollment in Phase IIb Trial of Synavive

Zalicus is a biopharmaceutical company that discovers and develops novel treatments for patients suffering from pain and immuno-inflammatory diseases. The company has a number of proprietary drug product candidates that are currently in clinical trials.

The company today announced it has completed the enrollment of 292 patients in the SYNERGY trial, a Phase 2b clinical trial designed to evaluate the safety and efficacy of the Zalicus’ Synavive drug. Synavive is a low-dose glucocorticoid with the potential for amplified immuno-inflammatory benefits in patients with rheumatoid arthritis.

The trial is a 12-week, five-arm, global, double-blind, placebo-controlled study designed to evaluate the company’s Synavive drug as a treatment for the signs and symptoms of rheumatoid arthritis in subjects with moderate to severe disease. The study is being conducted in up to 60 sites throughout the United States, Europe, and Latin America. The primary goal of the trial is to see the efficacy of Synavive versus a placebo, as well as compared to Prednisone and Dipyramidamole. The results of the study are expected in the third quarter of this year.

Patients who complete the SYNERGY trial are eligible to participate in a one-year extension study to evaluate the long-term safety and durability of response for Synavive. For additional information about Synavive and Zalicus’ other drug candidates, please visit the company’s website at www.zalicus.com

About MissionIR 

MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.

Sign up for “The Mission Report” at www.MissionIR.com

Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html

Somaxon Pharmaceuticals, Inc. (SOMX) and CJ CheilJedang Announce Collaborative Agreement for the Commercialization of Silenor® in South Korea

Somaxon Pharmaceuticals and CJ CheilJedang announced today that they have reached an agreement under which CJ CheilJedang will have the exclusive right to commercialize Silenor® (doxepin) in South Korea for the treatment of insomnia.

The terms of the agreement stipulate that Somaxon will collect an up-front payment of US$600,000. CJ CheilJedang will be responsible for regulatory submissions for Silenor and retains the exclusive right to commercialize Silenor in South Korea. Upon Silenor’s approval in South Korea, Somaxon will be eligible to receive sales-based milestone imbursements on top of a net sales based royalty of Silenor in South Korea. Somaxon will be supplying CJ CheilJedang’s requirements for commercial quantities of Silenor at a separate transfer price.

“This transaction helps us further our goal of maximizing the value of Silenor for our stockholders by selectively licensing rights to the product outside of the U.S.,” said Richard W. Pascoe, Somaxon’s President and Chief Executive Officer. “CJ CheilJedang is a leading pharmaceutical company in South Korea with an impressive track record of achieving regulatory approval and effectively commercializing branded pharmaceutical products.”

“We are pleased to partner with Somaxon to commercialize Silenor in South Korea,” said Seok-Hee Kang, Head of Pharmaceutical Business of CJ CheilJedang Corporation. “Silenor is an excellent fit with CJ CheilJedang’s commercial capabilities and portfolio, and we believe that there is a significant unmet need for Silenor.”

For more information, please visit www.silenor.com

About MissionIR 

MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.

Sign up for “The Mission Report” at www.MissionIR.com

Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html

Ampio Pharmaceuticals, Inc. (AMPE) Secures Key US/Canadian Patents for Diabetes-Related Vision Loss Drug Optina™

Today, Ampio Pharmaceuticals, the dynamic biopharma developer which has assembled an impressive portfolio of proprietary drugs for treating eye (diabetic macular edema – Optina™), kidney, and metabolic disease, as well as chronic inflammation (Ampion™), male sexual dysfunction (Zertane™), and central nervous system disease, reported reception of a notice of allowance for a patent from the United States Patent and Trademark Office covering Optina, also receiving a similar allowance from the Canadian Intellectual Property Office.

Diabetic macular edema (DME – fluid leaking into the area of the retina that provides sharp vision directly in front of you) and the diabetic retinopathy (the actual breaking down of tissues in the retina due to Type 1/2 diabetes that leads to) which causes it, are a serious problem resulting in vision loss and eventually blindness. There is no effective daily drug treatment and retinopathy occurs in almost all Type 1 cases (over 60% in Type 2) other than to regulate the conditional parameters (controlling blood sugar, blood lipid levels, hypertension, and the like), which exacerbate the fundamental problem.

Diabetic retinopathy is a massively underserved market that has exploded alongside the global diabetes epidemic, with the only options being unavailable in US/Canada and piecemeal at best (laser therapy and injection/implantation of drugs to/around the tissues).

So here is Optina, an ultra-low dose oral capsule form of danazol (the biphasic effect of which has been shown in endothelial cell permeability and f-actin cytoskeleton dynamics – Biochemical Biophysical Research Communications, Apr 2012), which basically tightens up the tissues that otherwise degrade. This biphasic effect of danazol (increasing or decreasing permeability at lower or higher concentrations) detailed in the BBRC publication (the first of what is to be a series), allows for modulated permeability. The mode of action then in Optina is essentially a modulation of the F-actin endoskeleton of the endothelial cells (which line the inside of blood vessels in the retina), resulting in better overall cohesion to the peripheral, or cortical actin, meaning the cell junctions are tight and leakage is reduced or eliminated.

AMPE has secured its footprint for Optina in North America with this move and has the requisite global patent ball rolling as well, with multiple additional patents pending worldwide. Since danazol (a derivative of the synthetic steroid ethisterone) was approved by the FDA back in the 1970s (for endometriosis, and more recently for chronic indications like fibrocystic disease of the breast, hereditary angioedema, and ITP), there is a very solid grounding for acceptance of the associated vascular dynamics.

CEO of AMPE, Michael Macaluso, emphasized the uncontested position of the drug, with no other oral drug being commercially available, or even known to exist for treatment of this condition. Macaluso cited the “unusually long” patent life spans granted (doesn’t expire until 2030), contrasting them with most other drugs at the same position on the timeline, just before a pivotal clinical trial, and staring at the very end of their patent life rapidly approaching like a freight train. Macaluso commented on ongoing discussions with potential partners to co-develop Optina, clearly excited about the DME potential and huge, underserved/unnerved market full of people who are at risk of going blind without such innovative products.

Chief Regulatory Officer at AMPE, Dr. Vaughan Clift, underscored the significance of the double masked, placebo controlled clinical study of Optina at Saint Michael Hospital in Toronto, which validated the in vitro findings regarding the extremely valuable function of a low dosage, as well as the inverse effect from a high dosage. The CRO is completely vetting the data from the Optina trial and AMPE intends to publish results via the proper venues after meeting with FDA to do a pre-IND run down of pivotal trials in the U.S. under 505(b)2 registration.

For more information on today’s patent announcement, or to stay up to date with the latest results out of this constantly innovating biopharma, please visit the Ampio Pharmaceuticals, Inc. website at: www.AmpioPharma.com


About MissionIR

MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.

Sign up for “The Mission Report” at www.MissionIR.com

Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html

Simulations Plus, Inc. (SLP) Releases Version 8.0 of Its Best-in-Class GastroPlus Simulation Software

Simulations Plus today announced it has released Version 8.0 of GastroPlus, its flagship simulation software. GastroPlus 8.0 features significantly enhanced functionality and user convenience, representing a substantial upgrade of the company’s industry-leading drug absorption, pharmacokinetics, and pharmacodynamics simulation software.

Among the features of GastroPlus 8.0 is the ability to simulate both inhibition and induction of transporters and enzymes in any tissue, as well as the ability to specify dissolution rates as function of pH, including fitting “Z Factor” from multiple in vitro dissolution experiments at different pH. GastroPlus 8.0 also enables enhanced modeling of drug absorption and distribution for ocular and pulmonary delivery, and the system features the addition of a paracellular permeability model that specifically accounts for drug movement between the epithelial cells lining the intestinal wall and transport into and through cells. The software comes equipped with an enhanced PDPlus module for building pharmacodynamics models and predicting pharmacodynamics effects for new doses and dosage forms, and it also features an expanded library of animal physiologies and expanded outputs for the Population Simulator. An increased execution speed and a number of user-convenience features and “sanity checks” round out the enhanced GastroPlus 8.0 software.

GastroPlus 7.0 was released in August 2010. The updated 8.0 version represents a combination of features requested by industry scientists as well as Simulations Plus’ own design. GastroPlus is utilized by the world’s top 20 pharmaceutical companies as well as many small and medium-sized companies across the globe.

Headquartered in California, Simulations Plus is a leading developer of pioneering drug discovery and development simulation and modeling software, which is licensed and used for conducting drug research by major pharmaceutical, biotechnology, chemical, and food processing companies around the world. For more information, visit www.simulations-plus.com

About MissionIR 

MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.

Sign up for “The Mission Report” at www.MissionIR.com

Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html

American Apparel, Inc. (APP) Launches Online Store in Hong Kong

On Thursday, Los Angeles-based clothing manufacturer American Apparel announced that it has launched a new online store that will service Hong Kong. The regional web store will be the company’s first direct e-commerce portal for its customers in Hong Kong. The new website is located at store.americanapparel.com.hk. Prior to the launch of this new site, customers shopped through the company’s international e-commerce store. Over time, Hong Kong had become the highest-performing international region without its own dedicated site.

In creating the new web store, the company will enhance its ability to serve consumers in the region in a number of new ways. To begin with, the site will accept orders placed in Hong Kong dollars. It will also allow for localization based on Hong Kong’s seasonal patterns and its schedule of holidays. While orders will still be fulfilled from the company’s Los Angeles-based factory, the move to the new store will decrease shipping costs for Hong Kong shoppers by $10 USD and will provide even better and timelier customer service.

Dov Charney, American Apparel founder and CEO, remarked, “Hong Kong is one of the most exciting regions in the world to run a business and we’re proud to expand our presence in the area. The parallels between American Apparel and Hong Kong itself–both founded on a bedrock of capitalism and free trade–are obvious and I think they’ll only help us in our exploration of this vibrant market.”

“We’re thrilled to offer our fans in Hong Kong their own local web store. We saw a fantastic opportunity to better serve our current clientele and hone our message to the region’s potential new customers,” added Christina Naetscher, web director for American Apparel.

To learn more about the company, visit www.americanapparel.net

About MissionIR 

MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.

Sign up for “The Mission Report” at www.MissionIR.com

Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html

RTI Biologics, Inc. (RTI) Releases 2012 First Quarter Results

RTI Biologics, a leading provider of orthopedic and other biologic implants, announced its operating results for the first quarter of 2012. Some highlights from the quarter are listed below:

– Achieved quarterly revenues of $43.7 million, an 8 percent increase over the first quarter of 2011 and exceeding the company’s guidance of between $41 and $42 million.

– Achieved quarterly earnings of $0.04 per fully diluted share, an increase of $0.02 compared to the first quarter of 2011 and exceeding the company’s guidance of $0.03 per fully diluted share.

– Achieved quarterly revenues of $13.4 million in the direct sports medicine business, an impressive 15 percent increase compared to the first quarter of 2011.

– Achieved quarterly revenues of $7.0 million in the bone graft substitutes and general orthopedic (BGS/GO) business, another impressive 15 percent increase compared to the first quarter of 2011.

– Achieved international revenues of $5.9 million, a 9 percent increase compared to the first quarter of 2011.

– Achieved quarterly revenues of $14.1 million in the U.S. direct distribution organization, a 16 percent increase over the first quarter of 2011. The U.S. direct distribution organization includes sports medicine and some BGS/GO implants.

“We are pleased with our first quarter results, which exceeded our expectations and were driven primarily by growth in our direct sports medicine and BGS/GO businesses, as well as in our dental business,” said Brian K. Hutchison, president and CEO of RTI.

Worldwide revenues were up 8 percent compared to the first quarter of 2011 to $43.7 million. Domestic revenues were up 7 percent compared to the first quarter of 2011 to $37.9 million. The increase can be attributed mainly to the strength of the sports medicine, BGS/GO, and dental businesses. International revenues of $5.9 million increased 9 percent compared to the first quarter of 2011 due to the strength of the surgical specialties business and the export of sports medicine and BGS/GO implants. After a constant currency adjustment, international revenues increased 12 percent compared to the first quarter of 2011.

For the first quarter of 2012, RTI reported net income of $2 million and net income per fully diluted share of $0.04, based on 55.9 million fully diluted shares outstanding, compared to net income of $1.2 million and net income per fully diluted share of $0.02 based on 55 million fully diluted shares outstanding.

About MissionIR 

MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.

Sign up for “The Mission Report” at www.MissionIR.com

Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html

ChinaNet Online Holdings, Inc. (CNET) Announces Partnership with China Business Journal

Yesterday, ChinaNet Online Holdings announced that the company has entered into a strategic partnership with China Business Journal (CBJ), in which the companies will cross-promote their respective services via each company’s networks of online and offline assets.

ChinaNet is focused on providing online to offline sales channel expansion service for small and medium-sized enterprises (SMEs) and entrepreneurial management and networking service for entrepreneurs based in China. ChinaNet provides advertising, in addition to other services, to Chinese companies via its portal websites 28.com, Liansuo.com, and Chuangye.com. ChinaNet also provides advertising through TV broadcast and in-store advertising in Chinese banks.

Under the terms of the partnership, the focus of the services will largely be on ChinaNets’ Liansuo.com website; where, starting in April of 2012, ChinaNet will run weekly ads in CBJ’s online and print publications. In return, ChinaNet will use its resources to help CBJ expand its existing subscription rate.

Handong Cheng, Chairman of ChinaNet, said, “This is an important strategic partnership that will provide significant benefits to ChinaNet and China Business Journal. Gaining access to approximately 200,000 business owners or business decision makers, we have an opportunity to generate significant incremental revenues over the next 9 to 24 months. Our joint collaboration will allow both companies to further expand our brands and provide valuable information and services to a wider audience and bring more businesses to each other based on the synergy that this partnership will create.”

To learn more about the company, visit www.chinanet-online.com

About MissionIR 

MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.

Sign up for “The Mission Report” at www.MissionIR.com

Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html

Echelon Corp. (ELON) Technical Analysis for Friday, April 27, 2012

Four straight up days appears to solidify the idea that a bottom has been established after a long-term downtrend. The indicators are showing a solid shift in trend and momentum which has the chart looking to test the 50 day moving average as resistance around $4.65. Bottom support is intact at $4.15.

To view the video chart, visit the following link: http://www.missionir.com/videos.html

About MissionIR 

MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.

Sign up for “The Mission Report” at www.MissionIR.com

Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html

Southern Products (SNPD) Accommodates EU Investors and Consumers with Dual Listing to Berlin Stock Exchange

Southern Products, a U.S. manufacturer of flat-panel televisions, today announced that as of April 20, 2012, the company was approved for a joint listing on the Berlin Stock Exchange (BSE) under the symbol ZSP. Southern Products also currently trades on the OTCBB, and said it chose to extend its trading platform accommodate its European shareholders and investors.

Southern Products noted several benefits to its dual listing on the BSE, including expectations it will improve the company’s image, reputation, and prestige on a global scale; expand the company’s ability to raise equity or debt financing; increase trading volume and liquidity; improve shareholder relations; and enhance overseas visibility among both investors and consumers.

The company retained Continental Advisors (Lux), knowledgeable in European Investments and trading and Continental, to arrange for the dual listing.

Andreea Porcelli of Continental Advisors agrees with the sentiment.

“Dual listings, sometimes called Cross-Border listings, literally open up an entirely new world of funders, investors, liquidity and potential shareholders to a company,” Porcelli stated in the press release. This dual listing will allow Southern Products to better serve its present and future European investors.”

For more information visit www.sigmacusa.com


About MissionIR 

MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.

Sign up for “The Mission Report” at www.MissionIR.com

Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html

SEFE, Inc. (SEFE) Reports Upcoming Test Parameters

Earlier this afternoon, SEFE unveiled the parameters for the forthcoming test of its proprietary detection system. The test will take place at a private facility in the Midwest.

Mike Hurowitz, Lead Engineer for SEFE, explained, “The flight detector system can be thought of as a ‘site survey’ tool to quickly identify operating parameters for the Harmony III system. It will be instrumental in perfecting our strategy for development, as well as our cost models. We will be pursuing aggressive testing over the next several months.”

This test will record atmospheric conditions, GPS location, and charge density/mobility measurements. This data is expected further enable SEFE’s team to determine the appropriate conditions to begin ground-based testing of the collection device.

For more information, visit www.SEFElectric.com

About MissionIR 

MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.

Sign up for “The Mission Report” at www.MissionIR.com

Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html

Koss Corp. (KOSS) Unveils the World’s First Wi-Fi Headphone System Capable of Receiving Music Directly from the Internet

Koss, creator of the world’s first SP3 Stereophone back in 1958, announced the unveiling of STRIVA, a cutting-edge headphone and in-ear monitor system equipped with Wi-Fi technology. This pioneering headphone system, utilizing Koss STRIVA technology, is the world’s first headphone system to wirelessly stream music directly from the Internet.

STRIVA TAP is a miniature in-ear monitor measuring only 1.5 inches in length. Unique from other in-ear cordless solutions, STRIVA TAPs do not require wires contained in a headband to connect the left and right earpieces. Instead, microprocessors in each earpiece continually synchronize music for consistent, quality stereo sound in both ears. STRIVA TAP users control the listening experience with capacitive touch controls on the device’s face.

Koss also has a solution for users who prefer over-the-head earphone models. The STRIVA PRO features gesture-based controls on the ear cup, which allows listeners to manage channel and volume preferences with a finger swipe or button flick. Both STRIVA PRO and STRIVA TAP come equipped with a STRIVA CAP that plugs into any headphone jack, and STRIVA CAP creates an additional local music channel for users who want to listen to their own personal music libraries or apps.

Development for STRIVA began nearly four years ago, and the process has yielded three significant technological breakthroughs. The first, STRIVA Core, is a miniature battery-powered computer that functions as a Web server and comes equipped with a variety of Wi-Fi components to make any device wireless. STRIVA Core’s Wi-Fi engine and microprocessor components are tiny enough to sit on the surface of a U.S. dime.

The next breakthrough, the MyKOSS server, links wirelessly with STRIVA products, connecting them to remote Internet broadcasting sites. The MyKOSS platform features proprietary software that scans the Internet for thousands of free streams and radio stations that deliver music and audio content.

Finally, all STRIVA products come equipped with the last innovation, STRIVA CAP (Content Access Point), which is a matchbook-sized wireless access point. STRIVA CAP converts music from a smartphone, music player, or computer into a digital TCP/IP stack and transmits it directly to STRIVA-enabled headphones or in-ear Wi-Fi monitors.

The Koss STRIVA system is the first wireless Wi-Fi system of its kind, and STRIVA-enabled headphones and in-ear monitors are the first products to directly connect to the Internet without dedicating a computer, smartphone, music player, or tablet to gather and deliver music. STRIVA Core is the first Wi-Fi-enabled computer that users wear on their heads, and the MyKOSS server software is the first controller system of its kind to exist in the cloud.

Koss Corporation is known across the globe for its high-fidelity stereoheadphones, audio accessories, and digital audiophile compact recordings of American orchestras on the Koss Classic Label. For more information, visit www.koss.com


About MissionIR 

MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.

Sign up for “The Mission Report” at www.MissionIR.com

Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html

Vringo, Inc. (VRNG) and du Agree to Launch Subscription Video Service, Expanding Vringo’s Potential Customer Base to Approximately 13 Million Subscribers

Vringo, a provider of software platforms for mobile social and video applications, announced today that it has reached an agreement with the United Arab Emirates’ integrated telecom service provider, du, to offer its esteemed mobile video service to du’s customers in the United Arab Emirates. This agreement boosts Vringo’s potential customer base to approximately 13 million subscribers within UAE’s two mobile operators. These two operators represent the entirety of the UAE wireless market.

“We are pleased to announce our latest carrier agreement with du in the United Arab Emirates,” said Andrew Perlman, Vringo’s President and Chief Executive Officer. “In the past few years, du has realized significant gains in market share and is growing further still. Now, as du makes a concerted effort to increase its data and value-added service offerings, our innovative technology will allow the mobile operator to provide an exciting new mobile video service to its growing subscriber base. We look forward to launching with du as we continue to expand Vringo’s reach in both the Middle East and other emerging markets around the world.”

“We are always looking for new, exciting ways in which to add to our customers’ experience, to add life to their life in the most surprising, value-adding ways. By partnering with Vringo, we are bringing a fresh, dynamic dimension to our customers’ experience,” said Farid Faraidooni, du’s Chief Commercial Officer.

The service Vringo will be providing to du customers is a video ringtone service consisting of a web, WAP, and mobile app experience that allows customers to create, download, and share high quality mobile video. Once Vringo’s service is active, du customers will gain access to all of the platform’s service capabilities, including Vringo’s extensive library of over 12,000 video ringtones.

For more information, please visit www.vringo.com


About MissionIR 

MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.

Sign up for “The Mission Report” at www.MissionIR.com

Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html

SEFE, Inc. (SEFE) Prepares to Launch New Brand Focused on Community Outreach

Today, SEFE announced that it will be launching a new content marketing site, Revmodo.com, next week on Tuesday, May 1, 2012. Geared towards attracting new business through community outreach initiatives and public education, the website is anticipated to be a huge business development asset of the company.

Shea Gunther and Michael d’Estries, two award-winning green marketing veterans whose experience ranges from Glamour and Huffington Post to Forbes and GE’s ecomagination.com, were tasked with developing the website. “The clean energy industry continues to evolve at a rapid pace and we’re proud to offer REVMODO as a new voice in a growing chorus of sites championing sustainable technologies and resources. By highlighting the incredible innovations of not only our parent company, but also the industry as a whole, we aim to attract new talent and foster growth of groundbreaking ideas,” said d’Estries.

Commenting on how the site fits into SEFE’s corporate strategy, CEO Don Johnston stated, “SEFE has always been geared toward finding and monetizing innovative ideas. We feel that Revmodo will provide us with unique opportunities to foster new concepts, as well as to allow access to a wide variety of potential business partners to drive revenue to our company.”

The Twitter account has been launched in advance of the website’s official debut. To start following, visit www.twitter.com/revmodo

For more information, visit www.SEFElectric.com


About MissionIR 

MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.

Sign up for “The Mission Report” at www.MissionIR.com

Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html

Stamps.com, Inc. (STMP) Reports Record-Breaking Quarter, Raises 2012 Guidance

Stamps, the leading provider of Internet-based postage solutions, yesterday reported impressive financial results for the first quarter of 2012. Also, Stamps said it had hit new record highs in several statistics it uses to track its business.

Stamps sells a wide variety of types of USPS postage, including First Class Mail®, Priority Mail®, Express Mail®, Media Mail®, Parcel Post®, and others. Stamps has mailing and shipping options for any sized business – all that’s needed is an Internet connection and a printer. With Stamps’ line of products and services, you can mail or ship from your home or office 24 hours a day, 7 days a week, all year round; never again enduring a long wait at the Post Office.

Stamps can print the address and postage together, saving you even more time. Its software can integrate with your own billing software, address lists, and word processing applications. Stamps’ customers can receive discounts on regular postal rates and can check on the validity of addresses in order to avoid wasted postage, among other advantages that let you print professional looking mail in less time and at less cost.

Asked to comment on the strong quarterly results, Ken McBride, Stamps.com Chairman and CEO, said, “The first quarter of 2012 was a great quarter for us with strong financial performance and a set of new records across several key customer metrics.”

“For the first quarter we matched our highest year-over-year growth rate in our core PC Postage revenue at 27%, we grew our total non-GAAP operating income by 70%, and we grew our total non-GAAP earnings per share by 41%,” he continued. “In addition, we set quarterly records in many of our key customer metrics including the largest number of new customers ever acquired in our SOHO [small office/home office] business and the largest sequential increase for our total paid customers since we began tracking that metric. We also continued to see strong growth in our enterprise and high volume shipping areas. As a result of the strength across all areas of our business, we raised our 2012 guidance today.”

Other highlights of the company’s first quarter include:

• Core PC Postage revenue was $26.2 million, up 27% from the first quarter of 2011.
• Total revenue was $28.3 million, up 24% compared to the first quarter of 2011.
• PC Postage gross margin was 76.9%.
• GAAP net income was $16.4 million, or $0.95 per fully diluted share. This includes $1.3 million in stock-based compensation expense and a non-cash income tax benefit of $11.9 million.
• Excluding the stock-based compensation expense and non-cash income tax benefit, non-GAAP income from operations was $5.7 million, non-GAAP net income was $5.8 million, and non-GAAP net income per fully diluted share was $0.34.

With its impressive 1Q 2012 results, Stamps currently expects fiscal 2012 total revenue to be in a range of $107.5 to $117.5 million. Last year, Stamps had estimated a lower range of $105 to $115 million. For 2012, the company estimates GAAP net income per share will fall somewhere in the range of $1.80 to $2.00. This estimate includes approximately $4 million of stock-based compensation expense and an $11.9 million non-cash tax benefit.

Stamps expects 2012 net income on a non-GAAP basis per diluted share will come in between $1.35 to $1.55, excluding stock-based compensation expense and the non-cash tax benefit. Previously, the company had expected 2012 non-GAAP EPS to be in the ballpark of $1.25 to $1.45 per fully diluted share, about 6% less than its revised forecast.

Stamps anticipates that income and revenue from its PhotoStamps retail box breakage will not be material for 2012. Had the box breakage income and revenue been excluded from 2011’s results, total revenue would have come in at $99.4 million yielding non-GAAP diluted earnings per share of $1.29. Stamps does not expect to invest heavily in its PhotoStamps product until there is material improvement in the economy.

To learn more about the company, visit http://investor.stamps.com

About MissionIR 

MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.

Sign up for “The Mission Report” at www.MissionIR.com

Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html

GlobalWise Investments, Inc. (GWIV) Led by Team of First-Class Executives

Through its wholly-owned subsidiary Intellinetics, GlobalWise Investments is a leading-edge technology company focused on the design, implementation, and management of Cloud-based ECM (Enterprise Content Management) systems. The founders of Intellinetics, Michael Chretien, his son Matthew Chretien, and Thomas Moss, now serve as GlobalWise executives, part of a group of software and computer related business experts that continue to move the company forward.

• William “BJ” Santiago (President & CEO) has over 20 years of executive level experience in both the public and private sectors. At Lexmark, he was chosen to launch and lead all operations for the newly formed Content Management Sales Practices operation for North America, based on the Intellinetics platform. Upon joining Intellinetics, he played a key role in driving the company’s business development and strategy.

• Matthew Chretien (EVP & Chief Technology Officer) is a strategic entrepreneur, with more than 20 years of experience in technology related sales, consulting, and software product life cycle management, within the aerospace, public safety, government, and select commercial markets. He went on to co-found Intellinetics in 1994.

• Michael Chretien (VP & Corporate Counsel) served the United States for 26 years in foreign counter intelligence and law enforcement, in addition to being in the Marines. After leaving government service, he achieved a law degree and co-founded Intellinetics, where he serves as Corporate Counsel.

• Thomas Moss (Chief Software Engineer), another co-founder of Intellinetics, has degrees in both mathematics and computer science, along with 20 years of experience in database application design and document imaging software technologies. He now serves as the company’s director of software R&D.

Intellivue™, the company’s flagship ECM platform, combines the power of the Cloud with on-demand solution templates, giving the client the ability to access and manage every piece of content they produce or receive, including paper documents, digital content, database print streams, and e-mail. Cloud technology makes the data accessible from virtually any PC, laptop, tablet, or smartphone, worldwide. Intellinetics is positioning itself to control the largely underserved small-to-mid sized business ECM marketplace, and is also viewed as a potential takeover target for their advanced Cloud technology.

For additional information on GlobalWiseInvestments, visit the company’s website at www.GlobalWiseInvestments.com, and see www.GlobalWiseInvestments.com/about-us/management for information on other key personnel.

About MissionIR 

MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.

Sign up for “The Mission Report” at www.MissionIR.com

Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html

Albany Molecular Research, Inc. (AMRI) Makes Key Addition to Its Management Team in Singapore

Albany Molecular Research is a global contract research and manufacturing firm offering customers fully integrated drug discovery, development, and manufacturing services. The company has a 21-year track record of success in the pharmaceutical and biotechnology industries in the United States, Europe, and Asia.

The company today announced a key addition to the management team at its Singapore facilities. AMRI named a new director of in vitro biology, Saravanakumar Dhakshinamoorthy, Ph.D., who will report directly to Takesi Yura, Ph.D., the senior director of AMRI Singapore. As leader of all the company’s biology resources in Singapore, Dr. Dhakshinamoorthy will be working on projects closely with his colleagues in the United States and India.

AMRI’s Singapore research center provides a full spectrum of drug discovery services to the pharmaceutical and biotechnology industries. Its capabilities support all the different sciences required to discover and advance new small molecule medicines. Some of these sciences include medicinal chemistry, in vitro biology, and DPMK (drug metabolism and pharmacokinetics). Preclinical drug candidates found this way are advanced by access to the company’s global development services.

Dr. Dhakshinamoorthy brings to AMRI more than 20 years of postgraduate experience in academic and industrial settings. He comes to the company after seven years with Aurigene, a discovery services company in Bangalore, India, and he also did work previously in Singapore with the Institute of Molecular and Cell Biology.

For additional information about Albany Molecular Research and the services it offers, please visit the company’s website at www.amriglobal.com

About MissionIR 

MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.

Sign up for “The Mission Report” at www.MissionIR.com

Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html

Australia’s Telstra Digital Chooses Lyris, Inc. (LYRI) Digital Marketing Solution to Power E-Marketing and Communications

Lyris, Inc., a provider of global digital marketing solutions, today announced that Telstra Digital, Australia’s primary telecommunications and information services company, has selected Lyris HQ to power its electronic marketing and transaction communications for Trading Post, Australia’s largest classifieds Web site.

Telstra Digital will utilize Lyris HQ to automate and accelerate the delivery of content based on customer behaviors and preferences. The technology is a significant step-up from Telstra’s previous methods.

“Before implementing Lyris HQ, we used manual processes to move data around that were neither cost-effective nor efficient,” Andrew Beecher, manager of consumer and digital marketing at Telstra Digital stated in the press release. “Implementing Lyris HQ will help us take Trading Post to the next level of customer engagement by fully automating our marketing and transactional communications. Our experience with Lyris has already far exceeded our expectations.”

Lyris HQ is a cloud-based digital marketing platform designed to maximize the effectiveness of high volume, complex campaigns while simplifying the delivery of relevant digital messages across e-mail, social, and mobile interaction channels. Lyris HQ also features list management, analytics, and landing page optimization.

“Telstra needed a messaging platform that could be deployed quickly to automate their processes and improve their customer experience,” said Adrian Saunders, general manager and senior vice president, APAC for Lyris. “Lyris delivers on that promise by combining easy-to-use digital message delivery with advanced segmentation and powerful analytics that will help Telstra expand and nurture their customer connections. We look forward to a long and productive partnership with one of Australia’s premier brands.”

For more information visit www.lyris.com


About MissionIR 

MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.

Sign up for “The Mission Report” at www.MissionIR.com

Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html

Cerus Corp. (CERS) to Collaborate with New York Blood Center to Develop Novel Red Blood Cell Biologic Product with Improved Uniformity

Cerus, a biomedical products company, and New York Blood Center (NYBC), one of the country’s largest nonprofit, community-based blood centers, announced they have entered into a research collaboration. The two entities will join forces to explore the potential for creating a red blood cell (RBC) biologic product that has improved uniformity compared to a standard unit of red blood cells.

Since RBC units are currently prepared from a single blood donation, there can be significant differences in the volume and hemoglobin content of individual units due to broad variability across the population of blood donors. The collaboration between Cerus and NYBC will explore whether small- to medium-scale pooling of RBC units can result in a product with more consistent characteristics – at the same time maintaining compatibility with major and most minor blood group antigens. Cerus’ INTERCEPT Blood System red cell pathogen inactivation process will be included as a step in the preparation of the novel red cell product, providing heightened protection against transfusion-transmitted disease. The use of advanced RBC storage solutions will also be explored for extending storage time and optimizing characteristics of the stored red cells.

The ultimate aim of the collaboration is providing a better, safer, and more uniform method of treating patients with anemia. Under the collaboration agreement terms, both organizations will support their own research effort costs. The commercialization terms for the end product will be negotiated once proof of principle has been established.

The Cerus INTERCEPT pathogen inactivation system has been designed to minimize the risk of transfusion-transmitted infections through inactivation of a wide range of pathogens, such as the viruses, bacteria and parasites that can be present in donated blood. The system has been approved in Europe for treating platelets and plasma and is being used by more than 100 blood centers in Europe, CIS, and the Middle East. Under development to treat individual RBC units, the INTERCEPT red cell system is scheduled to begin phase III trials in Europe later this year. The collaboration between Cerus and NYBC marks a new application for INTERCEPT technology – applying the pathogen inactivation treatment process to the novel red cell biologic product in development.

Cerus Corporation is a biomedical products company currently focused on commercializing the INTERCEPT Blood System, which Cerus presently markets and sells for both platelets and plasma in Europe, the Commonwealth of Independent States, the Middle East, and selected countries in other regions across the globe.

For more information, visit www.cerus.com

About MissionIR 

MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.

Sign up for “The Mission Report” at www.MissionIR.com

Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html

VistaGen Therapeutics (VSTA) Awarded U.S. Stem Cell Technology Patent Covering Methods Used to Test Drug Candidates for Liver Toxicity

VistaGen Therapeutics, Inc., a biotechnology company applying stem cell technology for drug rescue, just announced it has secured a new United States patent covering the company’s proprietary methods used to measure and type the toxic effects produced by drug compounds in liver stem cells.

Test methods included in this new patent, (U.S. Patent 11/445,733), titled “Toxicity Typing Using Liver Stem Cells,” cover all mammalian liver stem cells, including human cells. Liver stem cells used in drug testing can be derived from in vivo tissue or produced from embryonic stem cells (ES) or induced pluripotent stem cells (iPS).

H. Ralph Snodgrass, Ph.D., VistaGen’s President and Chief Scientific Officer, stated, “This patent covers the monitoring of changes in gene expression as an assay for predicting drug toxicities. It is well known that drugs activate and suppress specific genes, and that the changes in gene expression reflect the mechanism of drug toxicities. The specific sets of genes that are affected become a profile of that drug.”

VistaGen’s new patent also covers techniques used to develop a database of gene expression profiles of drugs that have the same type of liver toxicity. Using sophisticated “pattern matching” database tools, drug developers can analyze these related profiles to determine “gene expression signatures” that are common and predictive of drugs that produce specific types of toxicity.

“Without this database capability, a drug’s single gene expression profile could not
be interpreted,” Dr. Snodgrass added. “The ability to use liver stem cells to differentiate drug-dependent gene expression profiles, and to compare those profiles of drugs known to induce toxic liver effects, provides a powerful tool for predicting liver toxicity of new drug candidates, including drug rescue variants.”

Shawn K. Singh, VistaGen’s Chief Executive Officer, commented, “Strong and enforceable intellectual property rights are critical components of our plan to optimize the commercial potential of our Human Clinical Trials in a Test Tube™ platform. This new liver toxicity typing patent further solidifies our growing IP portfolio, and supports the continuing development of LiverSafe 3D™, our human liver cell-based bioassay system, which complements our CardioSafe 3D human heart cell-based bioassay system for heart toxicity.”

For more information, visit www.VistaGen.com

About MissionIR 

MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.

Sign up for “The Mission Report” at www.MissionIR.com

Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html

pSivida Corp. (PSDV) Announces Austria Has Granted Marketing Authorization to ILUVIEN® for the Treatment of Chronic Diabetic Macular Edema

pSivida Corp., a leader in developing sustained release drug delivery products for treatment of back-of-the-eye diseases, announced yesterday that ILUVIEN® has been granted marketing authorization from the Austrian Agency for Health and Food Safety (Osterreichische Agentur fur Gesundheit und Ernahrungssicherheit, AGES). ILUVIEN® is used in the treatment of vision impairment associated with chronic diabetic macular edema (DME) considered unsatisfactorily responsive to available therapies.

This marketing authorization comes on the heels of the completion of the Decentralized Regulatory Procedure. In this procedure the Medicines and Healthcare products Regulatory Agency in the United Kingdom delivered a positive outcome for ILUVIEN along with the six Concerned Members States of Austria, France, Germany, Italy, Spain, and Portugal. Austria gave ILUVIEN® its first national approval in the EU. Alimera expects further approvals to come soon and ILUVIEN® to be available in the EU by the end of 2012.

“We are very pleased ILUVIEN has received this marketing authorization and will soon be available to patients in Austria,” said Dr. Paul Ashton, president and chief executive officer of pSivida. “We look forward to ILUVIEN receiving the additional expected EU approvals.”

The International Diabetes Federation estimates that approximately 750,000 people are currently living with diabetes in Austria, and Alimera estimates more than 40,000 people suffer from DME and could potentially benefit from the use of ILUVIEN®.

For more information, please visit www.psivida.com

About MissionIR 

MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.

Sign up for “The Mission Report” at www.MissionIR.com

Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html

UQM Technologies, Inc. (UQM) Announces PowerPhase HD 220 Electric Propulsion System

UQM Technologies yesterday unveiled the company’s new PowerPhase HD 220 electric propulsion system, which UQM is calling its most powerful electric propulsion system ever. The product will make its official debut at the Electric Vehicle Symposium in Los Angeles, May 6-9.

Located in Longmont, CO, UQM is focused on designing and manufacturing electric motors and generators for use in several markets, including automotive and military markets. The company is also concentrating on developing products intended for use in alternative-energy technologies, which includes propulsion systems for electric, hybrid electric, plug-in hybrid electric, and fuel cell electric vehicles.

The new propulsion system offers heavy-duty vehicle classes, such as trucks and buses, a new alternative-energy solution. The PowerPhase has a maximum output of 220kW, and 120kW on a continuous basis; the system is currently production-ready to be manufactured in Colorado. UQM’s PowerPhase systems are already in use in the fleets of several companies, including Proterra, Electric Vehicles International, and UPS.

Eric Ridenour, UQM Technologies president and CEO, said, “The PowerPhase HD 220 is an important addition to our product line and represents a significant opportunity to grow our customer base and drive revenue and market share growth. The combination of significant power and high efficiency delivered by the HD 220 is ideal for the commercial heavy-duty trucks and bus markets.”


About MissionIR 

MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.

Sign up for “The Mission Report” at www.MissionIR.com

Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html

Uranium Energy Corp. (UEC) CEO to Take the Spotlight at the Milken Institute Global Conference

Uranium Energy Corp. just announced that the company’s President and CEO, Amir Adnani, will be speaking at the Milken Institute Global Conference on Monday, April 30, at 9:30am, at the Beverly Hilton in Los Angeles.

Mr. Adnani will participate in the panel discussion titled, “Natural Advantage: Canadian-U.S. Energy Resources,” alongside Kevin Lynch, Vice Chairman, BMO Financial Group, Rick Grafton, CEO and Chief Investment Officer, Grafton Asset Management; and Patrick Avery, President and CEO, Prospect Global Resources Inc. Moderator of the 1-1/4-hour panel discussion will be Conrad Kiechel, Director of Communications, of the Milken Institute Center for a Sustainable Energy Future.

According to the press release issued moments ago, panelists will address key policy issues involving the strong energy advantages of North America, which holds huge reserves of shale natural gas, oil sands, and uranium. Anticipated questions include: How can the U.S. and Canada use these natural resources to improve regional energy security? What policies will foster long-term investment?

The Milken Institute’s 15th Annual Global Conference attracts business and policy leaders interested in exploring solutions to urgent economic and social challenges. The Milken Institute is a nonprofit, independent economic think-tank whose mission is to improve the lives and economic conditions of diverse populations around the world by helping business and public policy leaders identify and implement innovative ideas for creating broad-based prosperity.

To learn more about Uranium Energy, visit www.UraniumEnergy.com

About MissionIR 

MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.

Sign up for “The Mission Report” at www.MissionIR.com

Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html

FluoroPharma Medical, Inc. (FPMI) Addresses Heart Disease with Unmatched Proprietary Products

In the marketplace, the principal strength of FluoroPharma Medical, developer of tracer agents for use with positron emission tomography (PET), is the uniqueness and effectiveness of their products. Their chemical agents, by highlighting certain biological processes in the body, allow PET technology to identify disease activity long before traditional symptoms appear. Their protected proprietary formulations offer clear advantages over competitor products, and, by focusing on the diagnosis of coronary artery disease (CAD), they address a major and largely unmet market need.

BFPET – FluoroPharma’s novel blood flow imaging agent is for use in conjunction with stress testing for the detection of ischemic and infarcted tissue within the heart muscle tissue of patients having suspected or proven chronic CAD. It enters the myocardial cells of the heart muscle in direct proportion to blood flow and membrane potential – the two most important physiological indicators of adequate blood supply to the heart. Specifically, the company believes that certain damaged heart tissue can be more reliably detected using BFPET. If approved, BFPET will represent the first molecular imaging blood flow agent commercialized for use in the cardiovascular segment of the PET imaging market.

CardioPET – A unique molecular imaging agent, CardioPET is designed to assess myocardial metabolism for the detection of ischemic and infarcted tissue, including for patients unable to undergo stress testing, as well as for cardiac viability assessment to predict functional improvement for revascularization patients. CardioPET would represent the first imaging agent available in the U.S. for use in patients with acute and chronic CAD that cannot undergo stress-testing, and could have other operational advantages as well.

VasoPET – Designed to detect vulnerable coronary artery plaque in patients with CAD, VasoPET addresses a significant unmet clinical objective. If approved, it would represent the first PET cardiac product to reliably image inflamed plaque and therefore may differentiate between vulnerable and stable coronary artery plaque. The rupture of such plaques and the subsequent formation of thrombi are currently recognized as the primary mechanisms of heart attacks and strokes.

FluoroPharma intends to be a leader in the discovery, development, and commercialization of innovative and targeted molecular imaging pharmaceuticals that improve disease detection.

For more information, see the company website at www.FluoroPharma.com

About MissionIR 

MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.

Sign up for “The Mission Report” at www.MissionIR.com

Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html

SuperMedia LLC (SPMD) SocialEze Solution Receives 2012 Local Search Association Excellence Award

U.S. local marketing advisor SuperMedia LLC has earned a 2012 Industry Excellence Award from the Local Search Association. The award was presented at the organization’s annual conference in Boca Raton, Fla.

The Local Search Association’s yearly conference allows attendees from around the world to review local search and advertising trends, receive and share ideas, learn of accomplishments in the field, and explore opportunities for improving service quality. SuperMedia’s SocialEze social media solution received recognition in the category of “Excellence in Social Marketing by a Publisher or Agency.” Each year, one solution is recognized that utilizes social media channels with user-generated content, such as Facebook or Twitter, for increasing documentable sales leads.

SocialEze is a user-friendly solution allowing small and medium-sized business to expand their relationships with consumers via social media. The solution offers automated tip posting, integration of business content, and competitively priced ongoing consultation with a social media expert.

SuperMedia is a local marketing advisor serving small to medium-sized business throughout the United States. The company helps businesses grow through effective local marketing solutions across print, online, mobile, and social media. Among SuperMedia’s solutions is the award-winning SuperGuarantee program, Superpages directories (published for Verizon, FairPoint and Frontier), EveryCarListed.com, Superpages for mobile, and Superpages direct mail products.

For more information, visit the company’s Web site at www.supermedia.com

About MissionIR 

MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.

Sign up for “The Mission Report” at www.MissionIR.com

Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html

Ramtron International Corp. (RMTR) Included in NVIDIA’s Preferred Vendor List; to Participate in GPU Technology Conference 2012

Ramtron International, a leading developer and supplier of nonvolatile ferroelectric random access memory (F-RAM) and integrated semiconductor products, announced that it is now included in NVIDIA’s Preferred Vendor List and has received an invitation to attend and participate in the GPU Technology Conference (GTC) 2012 in San Jose, CA, on May 14-17.

GPU computing is the process of using high-performance, energy-efficient graphics processing units (GPUs) to augment the performance of central processing units (CPUs) in any computing application. Specifically, GPUs process computationally intensive parallel portion of code to improve CPU functioning. GTC advances global awareness of the advantages of GPU computing and its impact on the progress of science and innovation.

GTC 2012 will feature the most cutting edge breakthroughs and rich content in GPU computing. The greatest minds in GPU computing will come together for four days of world-class education at GTC, showcasing the significant influence that parallel computing is having on scientific research, as well as commercial applications.

Ramtron F-RAM memory technology delivers high endurance, fast single-cycle and symmetrical read/write speeds, and low power consumption, in addition to gamma radiation tolerance and electromagnetic immunity. By introducing the breakthrough Ultra Low Energy memory technology, Ramtron reaches levels of power consumption that are not attainable in outdated, power hungry memory technologies.

For more information on the GPU Technology Conference, visit www.gputechconf.com

For more information on Ramtron International, please visit www.ramtron.com


About MissionIR 

MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.

Sign up for “The Mission Report” at www.MissionIR.com

Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html

Uranium Energy Corp. (UEC) Has the Unique Ability to Both Mine and Process Uranium

With nuclear power being recognized as the only existing large-scale proven source of carbon-free energy, other than hydroelectricity, nuclear power plants are being planned and built at a rate far in excess of the uranium needed to fuel them. Even now, the U.S. imports more uranium than it produces, a situation reflected around much of the world, and demand is increasing. It’s this anticipated demand for uranium that has fueled the growth of Uranium Energy and its expanding operations in south Texas.

Besides having the rights to a nationwide database of uranium exploration and mining activity, which has allowed it to target productive mining sites, UEC also has its own operating processing plant in Hobson, Texas, centrally located near its principal mining sites. There is a real need for additional processing plants in the country, and the computer controlled UEC processing plant is one of only two in the entire state of Texas. The uranium from UEC’s in-situ mining operations is trucked to the Hobson plant, where it is stored in water, which is gradually processed, filtered, and eventually dried to produce a heavy yellow powder called yellow cake. It is stored for shipment in drums and, being almost like powdered lead, each drum can weigh nearly a thousand pounds.

The important thing for UEC is that uranium in this form is worth roughly $50 per pound, depending upon the market, and the Hobson plant is expected to process about ¼ million pounds annually, which will continue to increase as new mines come online. The plant is currently allowed to process up to 1 million pounds per year, and has the physical capability of processing up to 2 million pounds per year, with further expansion possible. The goal is to have as many as 6 different projects feeding the plant, turning out up to 3 million pounds annually.

For more information, see the company website at www.UraniumEnergy.com

About MissionIR 

MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.

Sign up for “The Mission Report” at www.MissionIR.com

Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html

SEFE, Inc. (SEFE) Chosen to Sponsor Upcoming ELECTRIC POWER Conference and Exhibition

Earlier today, SEFE announced it will be a sponsor at the ELECTRIC POWER Conference and Exhibition in Baltimore, Maryland, May 15-17, 2012. The audience, which included over 170 power generating companies from more than 26 countries last year, is an excellent match for SEFE’s cutting-edge atmospheric energy technology.

The ELECTRIC POWER Conference & Exhibition was launched to meet the needs of operating management from power generating companies, both from the corporate office as well as from the power plant. Attendees have come to expect comprehensive coverage of strategic and technical issues from the event, which is programmed by the power industry for the power industry.

“Based on where we are in the research and development phase, the timing of this conference is ideal,” stated Don Johnston, CEO of SEFE, Inc. “We are hoping to further develop our relationships within the power and utility sector, as well as examine our options for expanding into high-potential areas.”

For more information on the conference, visit www.ElectricPowerExpo.com

For more information on the company, visit www.SEFElectric.com

About MissionIR 

MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.

Sign up for “The Mission Report” at www.MissionIR.com

Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html

ERF Wireless, Inc. (ERFB) to Discuss Recent Accomplishments and 2012 Outlook in Shareholder Conference Call and Webcast

ERF Wireless, a leader in providing enterprise-class wireless broadband products and services, announced it will host a shareholder conference call and live Web cast on Wednesday, May 23 at 3:30 p.m. Central. The Web cast, which will include a senior management presentation followed by a Q&A period, is expected to last approximately one hour. During the Q&A, ERF Wireless shareholders and investors will be able to ask questions about any subject, including the company’s recently filed 10-K Annual Report for 2011 and the 10-Q First Quarter Report for 2012 that will have been filed before the start of the Web cast.

ERF Wireless’ senior management team will discuss the considerable growth of the company’s oil and gas subsidiary, Energy Broadband. Also included in the Web cast will be updates about the company’s other operating divisions, including its WISP operations and ongoing initiatives in the banking, educational, and healthcare markets. Management will additionally outline ERF Wireless’ strategy for obtaining a national exchange listing later this year.

As reported in its Form 10-K, filed with the Securities and Exchange Commission in March, the financial condition of ERF Wireless improved greatly in 2011 as compared with the company’s previous fiscal year ended Dec. 31, 2010. This is indicative of the company’s continued progress toward its goals of profitability and obtaining a national marketing listing this year.

ERF Wireless reported 2011 revenues of $5,320,000 – a 43% increase from the previous year’s revenues of $3,708,000. Total comprehensive loss reported by the company was $3,404,000 for 2011 – a 60% improvement over the previous year’s losses of $8,511,000. The company’s Energy Broadband subsidiary reported 2011 revenues of $2,713,000 – an increase of 196% over the previous year’s revenues of $916,000.

ERF Wireless’ operating expenses for 2011 declined by 28% over the previous year, and the company’s liquidity position improved by $2,819,000 – including a $1,228,000 increase in current assets and a $1,591,000 decrease in current liabilities. The company invested $2,114,000 in cash during 2011, chiefly for the purchase of assets in its Energy Broadband subsidiary. ERF Wireless’ annual results also included a gross profit improvement of 119% as compared with the previous year.

Investors in the U.S. and Canada may use the following phone number to participate in the upcoming conference call:             (877) 407-9210      . International parties may dial             (201) 689-8049      . The live Web cast will be available via a link on the ERF Wireless Web site, www.erfwireless.com; a PowerPoint presentation will be included. Shareholders and investors not available to participate in the live call or Web cast may view a replay on the company Web site following the conference call. Submit questions by e-mail to questions@erfwireless.com or by fax to (281) 538-2121, attention: Clareen O’Quinn.

ERF Wireless is a fully reporting public corporation and the parent company of Energy Broadband, ERF Enterprise Network Services, ERF Wireless Bundled Services, ERF Wireless Messaging Services, and ERF Network Operations. Located in League City, Texas, the company provides wireless and broadband product and service solutions for enterprise, commercial, and residential clients across the globe. The company’s principals have been in the wireless broadband, network integration, triple-play FTTH, IPTV, and content delivery business for more than four decades.

For more information, visit www.erfwireless.com

About MissionIR 

MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.

Sign up for “The Mission Report” at www.MissionIR.com

Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html

SkyPeople Fruit Juice, Inc. (SPU) Provides Additional Information Regarding the Verification of its Fiscal Year End 2011 Cash Balances

SkyPeople Fruit Juice, a producer of fruit concentrates, fruit beverages, and other fruit-related products, has provided additional regarding their cash balances as of the end of its 2011 fiscal year.

As a product of a Nasdaq cash verification request, SkyPeople’s independent registered public accounting firm, Paritz & Company, P.A., from January 5 to January 9, 2012, independently verified SkyPeople’s cash balances held in Chinese financial institutions in which the company and its subsidiaries have bank accounts. In this instance “independently verified” means that Paritz & Company personally visited each of the financial institutions involved and physically observed bank employees printing or otherwise preparing or completing documentation substantiating the cash balance for the accounts in question. It is important to note the distinction between the independent verification performed in this case and an audit firm relying solely on documentation completed and returned by bank personnel by mail or facsimile.

Paritz & Company’s independent verification verified that the cash balances of the accounts represent substantially all of the cash, cash equivalents, and restricted cash amounts as previously stated in SkyPeople’s 2011 financial statements contained in the Company’s recent 10-K filing.

“At a time when there is speculation as to the credibility of certain Chinese companies, SkyPeople investors can be reassured that our cash balances have been independently verified and that we employ of a high degree of financial integrity in terms of our financial management systems,” said Mr. Yongke Xue, SkyPeople’s CEO. “Investors can have confidence in the strength of our balance sheet that enables us to take advantage of the growth opportunities available to us in our sector.”

For more information, please visit www.skypeoplefruitjuice.com

About MissionIR 

MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.

Sign up for “The Mission Report” at www.MissionIR.com

Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html

Tri-Tech Holding, Inc. (TRIT) Wins $7.02M Contract

Tri-Tech Holding recently announced that the company has been awarded multiple contracts with a total value of $7.02 million. Tri-Tech will provide flash flood warning systems and help implement small river hydrologic monitoring projects in five Chinese provinces.

Tri-Tech designs sewage treatment and odor control systems for both Chinese and international markets, along with systems that track natural waterway levels for drought control, monitor groundwater quality, and assist the Chinese government in managing its water resources. The company is also in the early stages of entering the industrial pollution market.

The $7.02M contract will see Tri-Tech providing flash flood monitoring and forecasting systems for the Heilongjiang, Fujian, and Guizhou provinces. The contract stipulates that the company will also implement small river hydrological monitoring systems for the Anhui and Shanxi provinces. Tri-Tech will either produce or obtain the equipment needed, as well as provide the installation and debugging of the resulting systems. The projects are scheduled for completion from the end of May through the end of July 2012.

Mr. Warren Zhao, Joint CEO of Tri-Tech, said, “As continued government policy support and fund allocation to water conservancy demonstrate, China’s water conservation industry is booming in 2012. As a leading solution provider in the industry, our company saw unprecedented growth in its flash flood early warning and small river systems business during the first quarter of 2012. By the time of this announcement, we have secured $16.5 million in flash flood early warning and small river hydrological monitoring system project contracts, already more than the total contract value we were awarded in all of 2011.”

Zhao continued, “As backlog from our water resources management business accumulated with growing sales, we focused on increasing the efficiency of the project implementation. As an update of the projects we were awarded for 20 countries and cities in Hunan, Henan, Hubei, Liaoning and Fujian from January to the mid of February in 2012: all major equipment for these projects has been delivered to project sites for installation and debugging. In order for the flash flood early warning and forecasting systems to function properly during the flood season, local governments are increasing and accelerating project bids. We anticipate our backlog from the business will continue to increase in the upcoming quarters as we seek to participate in new project bids.”

To learn more about the company, visit www.tri-tech.cn

About MissionIR 

MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.

Sign up for “The Mission Report” at www.MissionIR.com

Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html